1. An updated review on primary signet-ring cell carcinoma of the urinary bladder and report of a case. (4th March 2018) Authors: Lendorf, Maria Elisabeth; Dohn, Line Hammer; Á Dunga, Bara; Loya, Anand C.; Pappot, Helle Journal: Scandinavian journal of urology Issue: Volume 52:Number 2(2018) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial. Issue 4 (April 2016) Authors: Ruhlmann, Christina H; Christensen, Thomas Broe; Dohn, Line Hammer; Paludan, Merete; Rønnengart, Eva; Halekoh, Ulrich; Hilpert, Felix; Feyer, Petra; Kristensen, Gunnar; Hansen, Olfred; Keefe, Dorothy; Herrstedt, Jørn Journal: Lancet oncology Issue: Volume 17:Issue 4(2016:Apr.) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The iBLAD app protocol – a national, exploratory study on a multimodality smartphone app in bladder cancer for better understanding symptoms, quality of life and need for supportive care. (4th March 2023) Authors: Tolstrup, Lærke Kjær; Als, Anne Birgitte; Carus, Andreas; Dahlrot, Rikke; Dohn, Line Hammer; Holländer-Mieritz, Cecilie; Taarnhøj, Gry; Pappot, Helle Journal: Acta oncologica Issue: Volume 62:Number 3(2023) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗